🇺🇸 FDA
Patent

US 8808679

Auristatin compounds and conjugates thereof

granted A61KA61K31/4745A61K47/59

Quick answer

US patent 8808679 (Auristatin compounds and conjugates thereof) held by Mersana Therapeutics, Inc. expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Mersana Therapeutics, Inc.
Grant date
Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4745, A61K47/59, A61K47/64, A61K47/6803